CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells

Takeshita, A.; Yamakage, N.; Shinjo, K.; Ono, T.; Hirano, I.; Nakamura, S.; Shigeno, K.; Tobita, T.; Maekawa, M.; Kiyoi, H.; Naoe, T.; Ohnishi, K.; Sugimoto, Y.; Ohno, R.
July 2009
Leukemia (08876924);Jul2009, Vol. 23 Issue 7, p1329
Academic Journal
We studied the effect of CMC-544, the calicheamicin-conjugated anti-CD22 monoclonal antibody, used alone and in combination with rituximab, analyzing the quantitative alteration of target molecules, that is, CD20, CD22, CD55 and CD59, in Daudi and Raji cells as well as in cells obtained from patients with B-cell malignancies (BCM). Antibody inducing direct antiproliferative and apoptotic effect, complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) were tested separately. In Daudi and Raji cells, the CDC effect of rituximab significantly increased within 12 h following incubation with CMC-544. The levels of CD22 and CD55 were significantly reduced (P<0.001 in both cells) after incubation with CMC-544, but CD20 level remained constant or increased for 12 h. Similar results were obtained in cells from 12 patients with BCM. The antiproliferative and apoptotic effect of CMC-544 were greater than that of rituximab. The ADCC of rituximab was not enhanced by CMC-544. Thus, the combination of CMC-544 and rituximab increased the in vitro cytotoxic effect in BCM cells, and sequential administration for 12 h proceeded by CMC-544 was more effective. The reduction of CD55 and the preservation of CD20 after incubation with CMC-544 support the rationale for the combined use of CMC-544 and rituximab.Leukemia (2009) 23, 1329–1336; doi:10.1038/leu.2009.77; published online 16 April 2009


Related Articles

  • Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Adams, C.; Totpal, K.; Lawrence, D.; Marsters, S.; Pitti, R.; Yee, S.; Ross, S.; Deforge, L.; Koeppen, H.; Sagolla, M.; Compaan, D.; Lowman, H.; Hymowitz, S.; Ashkenazi, A. // Cell Death & Differentiation;Apr2008, Vol. 15 Issue 4, p751 

    Activation of the proapoptotic receptor death receptor5 (DR5) in various cancer cells triggers programmed cell death through the extrinsic pathway. We have generated a fully human monoclonal antibody (Apomab) that induces tumor cell apoptosis through DR5 and investigated the structural features...

  • Detection of surface asialoglycoprotein receptor expression in hepatic and extra-hepatic cells using a novel monoclonal antibody. Jung-Hyun Park; Kil Lyong Kim; Eun-Wie Cho // Biotechnology Letters;Jul2006, Vol. 28 Issue 14, p1061 

    The asialoglycoprotein receptor (ASGPR) is a heterodimeric membrane protein which is involved in the internalization of desialylated glycoproteins and also in the binding and uptake of various pathogenic viruses. To facilitate the analysis of ASGPR expression, we generated a monoclonal antibody,...

  • Monoclonal Antibodies Cross-Reactive with Group A Streptococci and Normal and Psoriatic Human Skin. Swerlick, Robert A.; Cunningham, Madeleine W.; Hall, Nancy K. // Journal of Investigative Dermatology;Sep86, Vol. 87 Issue 3, p367 

    Infection with group A streptococci has been implicated as a factor capable of exacerbating psoriasis. In order to explore the possibility of cross-reactivity between streptococcal antigens and human skin in this phenomenon, skin from psoriatic patients and control subjects was reacted with 3...

  • monoclonal antibody.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1486 

    An encyclopedia entry for "monoclonal antibody," which refers to the antibody which is specific to a certain antigen, is presented.

  • Insight into the roles of hypoxanthine and thydimine on cultivating antibody-producing CHO cells: cell growth, antibody production and long-term stability. Chen, Fei; Fan, Li; Wang, Jiaqi; Zhou, Yan; Ye, Zhaoyang; Zhao, Liang; Tan, Wen-Song // Applied Microbiology & Biotechnology;Jan2012, Vol. 93 Issue 1, p169 

    The potential of hypoxanthine and thymidine (H&T) to promote growth of CHO cells and production of monoclonal antibody (mAb) was explored in this study. It was demonstrated that H&T stimulated the initial cell growth and enhanced volumetric production of anti-human CD20 mAb by 22%, mainly...

  • Interaction of Trichohyalin with Intermediate Filaments: Three Immunologically Defined Stages of Trichohyalin Maturation. O'Guin, W. Michael; Sun, Tung-Tien; Manabe, Motomu // Journal of Investigative Dermatology;Jan1992, Vol. 98 Issue 1, p24 

    "Trichohyalin" is a 220-kD protein found in trichohyalin granules that are present as major differentiation products in the medulla and inner root sheath cells of human hair follicles. It was unclear whether this protein served as an inter- mediate filament precursor in the inner root sheath or...

  • Upping the ante on antibodies. Baker, Monya // Nature Biotechnology;Sep2005, Vol. 23 Issue 9, p1065 

    The article presents information on the current generation of antibodies. Sales of monoclonal antibodies grew by nearly 50% from 2003 to 2004, to $10.3 billion. The success of antibodies has infused biotechnology companies with cash and made pharmaceutical companies, once wary from early failed...

  • Differential expression of the islet-1 homeodomain protein in the limb bud of the chick embryo. Shiga, Takashi; Inoue, Kikuyo; Masuda, Tomoyuki // Anatomy & Embryology;Jun2002, Vol. 205 Issue 3, p223 

    Islet-1 and Islet-2 are members of a family of homeodomain-containing transcription factors, and Islet-1 has been shown to be involved in differentiation of several cell types. The expression pattern of Islet-1 and Islet-2 was examined in the presumptive limb buds of early chick embryos by using...

  • Identification of the Hemidesmosomal 500 kDa Protein (HD1) as Plectin1. Okumura, Masayo; Uematsu, Jun; Hirako, Yoshiaki; Nishizawa, Yuji; Shimizu, Hiroshi; Kido, Nobuo; Owaribe, Katsushi // Journal of Biochemistry;1999, Vol. 126 Issue 6, p1144 

    HDl is a 500 kDa hemidesmosomal plaque protein recognized by monoclonal antibody mAb-121. Recent research on inherited skin disease has suggested that it might be identical to plectin or an isoform. To cast light on this question, we have prepared several monoclonal antibodies that recognize a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics